- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04046458
De-escalating Vital Sign Checks
Using Predictive Analytics to Reduce Vital Sign Checks in Stable Hospitalized Patients
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Patients in the hospital often report poor sleep. A lack of sleep not only affects a patient's recovery from illness and their overall feeling of wellness, but it is a leading factor in the development of delirium in the hospital. One method for improving sleep in the hospital is to reduce the number of patient care related interruptions that a patient experiences. Vital sign checks at night are one example. In hospitalized patients who are clinically stable, vital sign checks that interrupt sleep are often unnecessary. However, identifying which patients can forego these checks is not a simple task. Currently, the hospital's quality improvement team asks physicians to think about this issue every day and order reduced, or "sleep promotion", vital sign checks on patients they believe could safely tolerate it. The investigators goal is to use a predictive analytics tool to reduce the cognitive burden of this task for busy physicians.
The investigators plan to develop a logistic regression model, trained on data from the electronic health record (EHR), to predict, for a given patient on a given night, whether they could safely tolerate the reduction of overnight vital sign checks. The model will use variables, such as the patient's age, the number of days they have been in the hospital, the vital signs from that day, the lab values from that day, and other clinical variables to make its prediction. The outcome is a binary variable, whether the patient will or will not have abnormal vital signs that night. The training data is retrospective therefore it contains the nighttime vitals that were observed, which the investigators will code as a binary variable and use as the outcome variable for the model to train against.
The investigators will incorporate this algorithm into an EHR alert so physicians can observe its output during their work, and use this information, complemented by their own clinical judgment, to decide about ordering reduced vital sign checks for a given patient.
The investigators will study the effect of this EHR alert on several outcomes: in-hospital delirium (measured by nurse assessment), sleep opportunity (a measurement, based on observational EHR data, of patient care related sleep interruptions), and patient satisfaction (measured by nationally-administered post-hospitalization HCAHPS surveys). Balancing measures, to ensure that reduced vital sign checks do not cause patient harm, will be rapid response calls and code blue calls.
Physician teams will be randomized to either see the EHR alert (intervention arm) or not see the EHR alert.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
California
-
San Francisco, California, Stati Uniti, 94143
- UCSF
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- All physician teams that operate under the UCSF Division of Hospital Medicine
Exclusion Criteria:
- N/A
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: EHR Alert
Physician teams will observe the EHR alert as they perform their clinical duties in the EHR.
|
A pop-up window in the EHR will notify a physician that their patient has been judged by a predictive algorithm to be safe for reduced overnight vital sign checks.
|
|
Comparatore placebo: No Alert
Physician teams will perform their clinical duties in the EHR as usual, with no visible alert.
|
No change to EHR function; no alert visible to providers
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
delirium
Lasso di tempo: average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Nursing Delirium Screening Scale (Nu-DESC score) - assessed by the nurse, can range from zero to ten, a score > 2 has good accuracy for delirium
|
average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
sleep opportunity
Lasso di tempo: average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
a *novel* measurement based on observational EHR data - for every night in the hospital, the investigators can extract from the EHR all event timestamps that could have interrupted the patient's sleep (measured between 11 pm and 6 am).
These are blood pressure recordings, fingerstick glucose checks, blood draws for labs, and not-as-needed medication administrations.
The maximum time period between such events is considered the patient's sleep opportunity for that night (measured in hours).
A higher sleep-opportunity on a given night is better.
The investigators can calculate an average sleep-opportunity for a hospital encounter and then an average sleep-opportunity for all encounters in a clinical trial arm.
|
average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
patient satisfaction
Lasso di tempo: average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
results from Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys administered to patients after discharge from the hospital (scale is a categorical response: never, sometimes, usually, or always)
|
average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
number of code blue events
Lasso di tempo: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a code blue (respiratory or cardiac arrest) called on them in the hospital, the resuscitation team that responds then writes a note documenting the event; the investigators can count these notes as a proxy for counting code blue events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
number of rapid response calls
Lasso di tempo: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a rapid response (significant change in vital signs or alertness) called on them in the hospital, the team that responds writes a note documenting the event and the investigators can count these notes as a proxy for counting rapid response events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
Collaboratori e investigatori
Investigatori
- Direttore dello studio: Mark Pletcher, MD, Director of the UCSF Informatics and Research Innovation Program
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- nightvitals
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Delirio
-
Chimei Medical CenterNon ancora reclutamento
-
University Hospital, Basel, SwitzerlandNon ancora reclutamentoDelirium Stato confusionale
-
University of Southern CaliforniaTerminatoDelirio | Effetti collaterali del trattamento | Moralità | Delirio in età avanzata | Psico | Delirio di origine mista | Delirium Stato confusionale | Delirium, associato a sepsiStati Uniti
-
University of ChileFondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT (Chile).Sconosciuto
-
Duke UniversityNon ancora reclutamentoDelirium Stato confusionale | Delirio iperattivo | Delirio in Terapia Intensiva | Delirio AgitatoStati Uniti
-
Jubilee Mission Medical College and Research InstituteINCRE fellowship from DBT, govt of IndiaCompletatoSintomi di astinenza da alcol | Delirium Tremens (DT)
-
Ain Shams UniversityNon ancora reclutamento
-
University Hospital OstravaReclutamentoEmergence Delirium, anestesiaCechia
-
University of Medicine and Pharmacy at Ho Chi Minh...SconosciutoIncidenza del delirium nei pazienti anziani ricoveratiVietnam
-
Assiut UniversityNon ancora reclutamentoEmergence Delirium, anestesiaEgitto
Prove cliniche su Nighttime Vital Sign EHR Alert
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompletato
-
Lady Davis InstituteCarebook Technologies Inc.SconosciutoMalattie vascolari | Coronavirus | Malattia respiratoria | Malattia cardiaca